ArticleCell reports. Medicine2022

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.

Rebeca Uceda-Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.